FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226052492> ?p ?o ?g. }

• W4226052492 endingPage "44" @default.
• W4226052492 startingPage "35" @default.
• W4226052492 abstract "Introduction: Antiphospholipid syndrome (APS) is an autoimmune disorder manifested by arterial or venous thromboses and/or spontaneous abortions associated with a persistently elevated level of antiphospholipid antibodies. To date, no clear relationship has been established between levels and types of autoimmune antibodies and clinical manifestations of APS, which can range from mild coagulation disorders to life-threatening conditions. Aim: The aim of this study is to examine the relation between antiphospholipid antibody type and titer and the most common clinical manifestations of APS. Materials and methods: The retrospective study included 32 patients with a confirmed laboratory finding of elevated antiphospholipid antibodies, who came for follow-up examinations to the Hemophilia Unit of the University Clinical Center of Serbia, between June 1, 2017 and December 31, 2018. Data on patients were taken from their medical records. Basic demographic data, type and titer of antiphospholipid antibodies, and their association with the present clinical manifestations of APS were analyzed using standard statistical methods. Results: There was no significant difference regarding the frequency of positive results for lupus anticoagulant, anti-cardiolipin, and anti-beta-2-GP-I antibodies, between the symptomatic and asymptomatic group. The percentage of persons with simultaneous positivity for two or all three antiphospholipid antibodies was the same in both groups of subjects. Conclusion: As opposed to previous studies, our study did not demonstrate a correlation between the titer of antiphospholipid antibodies and the clinical manifestations of APS. Symptomatic and asymptomatic patients did not significantly differ in the frequency of elevated antibodies. These results indicate that the presence of other factors, which are as yet little-known, is necessary for the clinical manifestations of APS." @default.
• W4226052492 created "2022-05-05" @default.
• W4226052492 creator A5046349609 @default.
• W4226052492 creator A5085988624 @default.
• W4226052492 date "2022-01-01" @default.
• W4226052492 modified "2023-09-26" @default.
• W4226052492 title "Investigation of the relation between the type and titer of antiphospholipid antibodies and the clinical manifestations of antiphospholipid syndrome" @default.
• W4226052492 cites W1491481195 @default.
• W4226052492 cites W1991721757 @default.
• W4226052492 cites W1999555834 @default.
• W4226052492 cites W2042958596 @default.
• W4226052492 cites W2044043417 @default.
• W4226052492 cites W2054330426 @default.
• W4226052492 cites W2084030336 @default.
• W4226052492 cites W2084234423 @default.
• W4226052492 cites W2119266650 @default.
• W4226052492 cites W2163384287 @default.
• W4226052492 cites W2739493374 @default.
• W4226052492 cites W3022177047 @default.
• W4226052492 cites W4239987606 @default.
• W4226052492 doi "https://doi.org/10.5937/smclk3-32463" @default.
• W4226052492 hasPublicationYear "2022" @default.
• W4226052492 type Work @default.
• W4226052492 citedByCount "0" @default.
• W4226052492 crossrefType "journal-article" @default.
• W4226052492 hasAuthorship W4226052492A5046349609 @default.
• W4226052492 hasAuthorship W4226052492A5085988624 @default.
• W4226052492 hasBestOaLocation W42260524921 @default.
• W4226052492 hasConcept C126322002 @default.
• W4226052492 hasConcept C159654299 @default.
• W4226052492 hasConcept C203014093 @default.
• W4226052492 hasConcept C2776874634 @default.
• W4226052492 hasConcept C2777910003 @default.
• W4226052492 hasConcept C2780022809 @default.
• W4226052492 hasConcept C32611913 @default.
• W4226052492 hasConcept C71924100 @default.
• W4226052492 hasConcept C90924648 @default.
• W4226052492 hasConceptScore W4226052492C126322002 @default.
• W4226052492 hasConceptScore W4226052492C159654299 @default.
• W4226052492 hasConceptScore W4226052492C203014093 @default.
• W4226052492 hasConceptScore W4226052492C2776874634 @default.
• W4226052492 hasConceptScore W4226052492C2777910003 @default.
• W4226052492 hasConceptScore W4226052492C2780022809 @default.
• W4226052492 hasConceptScore W4226052492C32611913 @default.
• W4226052492 hasConceptScore W4226052492C71924100 @default.
• W4226052492 hasConceptScore W4226052492C90924648 @default.
• W4226052492 hasIssue "1" @default.
• W4226052492 hasLocation W42260524921 @default.
• W4226052492 hasOpenAccess W4226052492 @default.
• W4226052492 hasPrimaryLocation W42260524921 @default.
• W4226052492 hasRelatedWork W1565966142 @default.
• W4226052492 hasRelatedWork W2059688776 @default.
• W4226052492 hasRelatedWork W2098420608 @default.
• W4226052492 hasRelatedWork W2156299866 @default.
• W4226052492 hasRelatedWork W2319931263 @default.
• W4226052492 hasRelatedWork W2411185407 @default.
• W4226052492 hasRelatedWork W2470695382 @default.
• W4226052492 hasRelatedWork W2801430558 @default.
• W4226052492 hasRelatedWork W4254531810 @default.
• W4226052492 hasRelatedWork W775515118 @default.
• W4226052492 hasVolume "3" @default.
• W4226052492 isParatext "false" @default.
• W4226052492 isRetracted "false" @default.
• W4226052492 workType "article" @default.